Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Carterra logo — High-throughput discovery and characterization technology

Carterra

High-throughput discovery and characterization technology

Founded 2005 United States Salt Lake City, United States 78 employees Venture round Total: $38.07M Biotechnology, Platforms

General Information

Company Name Carterra
Founded Year 2005
Location United States Salt Lake City, United States
Founders / Decision Makers
Team member
Employees 78
Industries Biotechnology, Platforms
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Carterra. To contact Carterra, visit carterra-bio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Carterra compare?

A PDF of Carterra and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Carterra soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Carterra

Carterra is a privately held biotechnology company based in the United States, founded in 2005. The company's slogan, "High-throughput discovery and characterization technology," aligns with its focus on accelerating and improving the discovery of novel therapeutic candidates. The recent $8.09M Venture Round investment on 14 December 2020 from Ballast Point Ventures, Telegraph Hill Partners, and PerkinElmer signifies confidence from notable investors in Carterra's innovative technologies. Carterra's flagship product, the LSA® instrument, is designed to deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other systems. This breakthrough is achieved through a combination of patented microfluidics technology with real-time high-throughput Surface Plasmon Resonance (HT-SPR) and industry-leading data analysis and visualization software. The company's new LSA-XT with enhanced optics promises additional applications in biotherapeutic discovery and characterization. With Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester, England, and Munich, Germany, Carterra is strategically positioned to cater to its global clientele. Furthermore, its products are available in the Asia-Pacific and Oceania regions through exclusive distributor Revvity. Carterra's focus on high-throughput technologies, backed by recent investments and a strong global presence, positions the company as a key player in revolutionizing mAb screening and advancing biotherapeutic discovery and characterization. For additional information, visit www.carterra-bio.com.

Business keywords: biotherapeutic discovery, high-throughput technology, LSA instrument, microfluidics technology, Surface Plasmon Resonance, mAb screening, biotech equipment, Salt Lake City, real-time analysis, optical technology, data visualization, global distribution, exclusive distributor

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $8.09M 3
Ballast Point Ventures Telegraph Hill Partners
Ballast Point Ventures, Telegraph Hill Partners +1
14 Dec 2020
Venture Round $6.00M 2
Ballast Point Ventures Telegraph Hill Partners
Ballast Point Ventures, Telegraph Hill Partners
14 Jan 2020
Venture Round $10.00M 1
Telegraph Hill Partners
Telegraph Hill Partners
17 Jan 2018
Venture Round $10.30M 1
PC Squared, LLC
18 Aug 2016
Venture Round $2.00M 1
Kirk Ririe
01 Jul 2014
Venture Round $482.63K 1
PC Squared, LLC
03 Jan 2014
Venture Round $1.00M -
25 Apr 2012
Seed Round $200.00K 2
Tech Coast Angels
Tech Coast Angels, PC Squared, LLC
25 Jan 2012

Carterra Alternatives & Competitors

Carterra vs
Nicoya
Nicoya Canada

Our mission is to improve human life by helping scientists succeed.

Series A
124 employees
Biotechnology, Platforms
Compare Carterra vs Nicoya

FAQ About Carterra

High-throughput discovery and characterization technology
Carterra was founded in 2005.
Carterra is headquartered in Salt Lake City, United States.
Carterra operates in Biotechnology and Platforms. Its work centres on biotherapeutic discovery, high-throughput technology, LSA instrument and microfluidics technology.
Carterra has approximately 78 employees.
Carterra has completed 8 funding rounds, raising a total of $38.07M. The latest funding stage is Venture round.
Top alternatives and competitors to Carterra include Nicoya. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Carterra and Nicoya are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Carterra, https://bouncewatch.com/company/carterra, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout